Annie Wong 黃毅敏
@anmwongnz.bsky.social
370 followers 400 following 34 posts
🇳🇿Medical Oncologist👩🏻‍⚕️Senior lecturer University Otago Wellington/Auckland 👩🏻‍🏫 Mother🤱🏻 Food enthusiast👩🏻‍🍳#MedEd
Posts Media Videos Starter Packs
Reposted by Annie Wong 黃毅敏
Reposted by Annie Wong 黃毅敏
togaanz.bsky.social
Happening tomorrow!

We're looking forward to seeing you at the Optimal Care Pathway for Lung Cancer in an Evolving Field Workshop.

Registrations/lunch from 12:00pm.
Reposted by Annie Wong 黃毅敏
jiajennyliu.bsky.social
One week until the inaugural #ESMOTATAsia25 🤩
I'm looking forward to joining global drug development experts in🍜🇭🇰
+ sharing insights on dose optimisation of novel combinations
🗓️ Saturday 19 July 2pm.
@myesmo.bsky.social @herbloongmd.bsky.social @anmwongnz.bsky.social
Reposted by Annie Wong 黃毅敏
aspire-cop.bsky.social
📘 Just launched: the first-ever clinical casebook focused solely on immune-related toxicities. 65 expert-contributed cases across 10+ organ systems. Essential reading for the #irAE frontlines. Grab your copy 👉 link.springer.com/book/10.1007...
#irAE #OncologyBooks @ascocancer.bsky.social #ASPIRE
Challenging Cases in Immunotherapy Related Organ Toxicities
This is a book that focuses on examples of challenging cases with toxicities presented in different organ systems
link.springer.com
anmwongnz.bsky.social
Was chatting to my registrar about transitioning to life as a new consultant

🤩remembered @theracp.bsky.social has a handbook on this!

www.racp.edu.au/docs/default...

What are your top tips?

#MedEd #Newfaculty
www.racp.edu.au
Reposted by Annie Wong 黃毅敏
aspire-cop.bsky.social
🚀 That's a wrap #ASCO25! Join ASCO’s #ASPIRE Community of Practice, the go-to hub for clinicians addressing immune-related toxicities!
🌟 FREE access for non-oncologists (for a limited time)
💬 Engage in virtual meetings, expert discussions, and access curated content!
docs.google.com/forms/d/1zfl...
ASPIRE MEMBERSHIP FORM
To unite the global medical community to advance clinical practice, education, and research in the prevention, diagnosis, and management of immune-related adverse events (irAEs) from immunomodulating ...
docs.google.com
Reposted by Annie Wong 黃毅敏
anmwongnz.bsky.social
Such important work @aspire-cop.bsky.social team. Crucial to collect the right info to improve our understanding of immunotherapy toxicities and plan the right supportive care for our patients

#IOtox #supportivecare #immunotherapy
aspire-cop.bsky.social
Did you know the ICD10 codes to identify patients experiencing immunotherapy toxicity? @kmittalmd.bsky.social presents these codes as a system-based approach to capture #irAE impact @funchainmd.bsky.social @kerryreynoldsmd.bsky.social @mazietsangmd.bsky.social @ascocancer.bsky.social
Reposted by Annie Wong 黃毅敏
aspire-cop.bsky.social
Did you know the ICD10 codes to identify patients experiencing immunotherapy toxicity? @kmittalmd.bsky.social presents these codes as a system-based approach to capture #irAE impact @funchainmd.bsky.social @kerryreynoldsmd.bsky.social @mazietsangmd.bsky.social @ascocancer.bsky.social
Reposted by Annie Wong 黃毅敏
aspire-cop.bsky.social
🌟Calling all #ASCO25 presenters!🌟 Are you showcasing an #irAE poster? #ASPIRE wants to spotlight your incredible work! 🙌 Join us in advancing knowledge in this vital field!✨ @ascocancer.bsky.social @kmittalmd.bsky.social @funchainmd.bsky.social @kerryreynoldsmd.bsky.social @oncoalert.bsky.social
Reposted by Annie Wong 黃毅敏
ericroeland.bsky.social
🌟 Got questions about #irAEs? 🤔 What about tumor deposits in the lung or liver—do they heighten the risk? Recent retrospective data from hospitalized patients suggests an association 🚨 jitc.bmj.com/content/13/5... #ASPIRE @aspire-cop.bsky.social @kerryreynoldsmd.bsky.social @funchainmd.bsky.social
Reposted by Annie Wong 黃毅敏
myesmo.bsky.social
📣 #ESMOFellowship: Check out the practical tips from Teresa Amaral and Evandro de Azambuja on how to make your application stand out.

📅 Apply by 29 May 2025 at 12.00 AM CEST

🔗 ow.ly/ANRS50VVret
Reposted by Annie Wong 黃毅敏
mathewgwilson.bsky.social
Blessed to have mentors who are the driving force of lung cancer research in New Zealand @anmwongnz.bsky.social & Laird Cameron.

#NewZealand #LCSM #Oncsky
anmwongnz.bsky.social
Super proud of our team Drs Laird Cameron, Sandra Fitzgerald getting our 1st Auckland patient into our FAST 🫁 🧬 ctDNA study today 🤩🤩🤩

Laird & I first dreamed up the study while at @myesmo.bsky.social Asia Singapore Dec22!!!

Good things take time ❤️ so fun to do research w one of my besties!
anmwongnz.bsky.social
Super proud of our team Drs Laird Cameron, Sandra Fitzgerald getting our 1st Auckland patient into our FAST 🫁 🧬 ctDNA study today 🤩🤩🤩

Laird & I first dreamed up the study while at @myesmo.bsky.social Asia Singapore Dec22!!!

Good things take time ❤️ so fun to do research w one of my besties!
Reposted by Annie Wong 黃毅敏
togaanz.bsky.social
Early bird registrations are open for TOGA's 2025 ASM!

The theme of this year’s hybrid event is ‘Implementing Change in Thoracic Cancer Care Through Multidisciplinary Innovation’, with a special focus on bringing evidence-based solutions into practice using implementation science.
anmwongnz.bsky.social
Beyond excited about Pharmac’s proposed melanoma drug funding from 1st June!

🙏🙏🙏Alex van Akkooi @melanomaau.bsky.social & Hannah Farnsworth @petermaccc.bsky.social for sharing their surgical and nursing experience in Melnet’s virtual session on perioperative melanoma management next Tuesday.
Reposted by Annie Wong 黃毅敏
togaanz.bsky.social
Get ready to hear from Kelvin Lau, presenting on Robot Assisted Endobronchial Intervention at the 2025 TOGA ASM!

Don't miss this chance to hear from leading experts.

📅 Save the date: July 30 – August 1
📍 Location: Brisbane Convention & Exhibition Centre

Check out the program > buff.ly/7YecVX1
anmwongnz.bsky.social
Felt so honoured to be gifted this Māori taonga (treasure) after an uplifting day at the marae: learning with our community cancer navigators & our cancer support team!

A sacred symbol of our collaboration, united together for our patients & whanau ❤️

🙏TY for invite!

#maoriculture #oncology #MedEd
Reposted by Annie Wong 黃毅敏
fumikochino.bsky.social
🎙️It's not one size fits all with cancer care. We're trying to make a customized plan & [rally] all of the modern technologies to make sure that we're rightsizing the treatments for the individual.

And I think that provides a lot of benefits for patients.

#breastCancer #bcsm
@ascocancer.bsky.social
Treatment De-escalation for Favorable Risk Breast Cancer | Podcast | ASCO Publications
Dr. Chino talks with Dr. Atif Khan and Dr. Lola Fayanju about the shift in breast cancer management from reducing locoregional recurrence and improving breast cancer mortality to deintensification, sh...
ascopubs.org
Reposted by Annie Wong 黃毅敏
mtmdphd.bsky.social
NIVOPOSTOP (GORTEC 2018-01): Ph3 RCT of adjuvant nivolumab added to radio-chemotherapy in Pts w/ resected head & neck squamous cell carcinoma at high risk of relapse - Bourhis et al. #ASCO25 LBA2 meetings.asco.org/abstracts-pr... #NCT03576417 #hncsm #ImmunoOnc
Program Guide – ASCO Meeting Program Guide
meetings.asco.org
Reposted by Annie Wong 黃毅敏
myesmo.bsky.social
⏰Less than 2 weeks left to submit your abstract to #ESMOTATAsia25! A fantastic opportunity to showcase your transformative work within the region in a truly international platform.

👉Submit your research by 29 April by 18:00 Hong Kong Time

🔗 buff.ly/nOD4Kzs